STERIS plc (NYSE:STE) Shares Purchased by Fidelis Capital Partners LLC

Fidelis Capital Partners LLC increased its position in shares of STERIS plc (NYSE:STE) by 8.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 1,032 shares of the medical equipment provider’s stock after acquiring an additional 84 shares during the quarter. Fidelis Capital Partners LLC’s holdings in STERIS were worth $225,000 as of its most recent filing with the SEC.

A number of other hedge funds have also recently bought and sold shares of the company. Jones Financial Companies Lllp boosted its position in STERIS by 19.4% during the fourth quarter. Jones Financial Companies Lllp now owns 757 shares of the medical equipment provider’s stock worth $156,000 after acquiring an additional 123 shares during the last quarter. Norden Group LLC boosted its position in STERIS by 2.9% during the fourth quarter. Norden Group LLC now owns 4,023 shares of the medical equipment provider’s stock worth $827,000 after acquiring an additional 115 shares during the last quarter. Middleton & Co. Inc. MA boosted its position in STERIS by 0.9% during the fourth quarter. Middleton & Co. Inc. MA now owns 49,135 shares of the medical equipment provider’s stock worth $10,100,000 after acquiring an additional 427 shares during the last quarter. Anfield Capital Management LLC boosted its position in STERIS by 100.0% during the fourth quarter. Anfield Capital Management LLC now owns 182 shares of the medical equipment provider’s stock worth $37,000 after acquiring an additional 91 shares during the last quarter. Finally, Metis Global Partners LLC boosted its position in STERIS by 24.3% during the fourth quarter. Metis Global Partners LLC now owns 6,772 shares of the medical equipment provider’s stock worth $1,392,000 after acquiring an additional 1,322 shares during the last quarter. Institutional investors and hedge funds own 94.69% of the company’s stock.

Analyst Ratings Changes

A number of brokerages have weighed in on STE. Needham & Company LLC reiterated a “hold” rating on shares of STERIS in a report on Friday, November 8th. JMP Securities reiterated a “market outperform” rating and issued a $265.00 price target on shares of STERIS in a report on Thursday, February 6th. Stephens reiterated an “overweight” rating and issued a $240.00 price target on shares of STERIS in a report on Thursday, February 6th. Finally, Piper Sandler lifted their price target on shares of STERIS from $260.00 to $265.00 and gave the company an “overweight” rating in a report on Monday, February 3rd. One analyst has rated the stock with a hold rating and five have given a buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $258.75.

STERIS Stock Performance

Shares of STE stock opened at $227.51 on Thursday. The company’s fifty day simple moving average is $215.99 and its 200-day simple moving average is $222.79. STERIS plc has a 52 week low of $197.82 and a 52 week high of $248.24. The company has a current ratio of 2.13, a quick ratio of 1.40 and a debt-to-equity ratio of 0.32. The company has a market cap of $22.35 billion, a PE ratio of 48.30 and a beta of 0.84.

STERIS (NYSE:STE) last released its quarterly earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.33 by ($0.01). STERIS had a return on equity of 13.91% and a net margin of 8.66%. As a group, equities research analysts anticipate that STERIS plc will post 9.08 EPS for the current year.

STERIS Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, March 21st. Stockholders of record on Thursday, February 20th will be given a $0.57 dividend. This represents a $2.28 annualized dividend and a dividend yield of 1.00%. The ex-dividend date is Thursday, February 20th. STERIS’s payout ratio is currently 48.41%.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.